News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
SULIMAN SHEHNAAZ
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2023 |
4
| SULIMAN SHEHNAAZ (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Granted 1,865 shares
@ $0
Granted 4,661 options to buy
@ $57.62, valued at
$268.6k
|
|
| 06/09/2023 |
4
| SULIMAN SHEHNAAZ (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 3,860 shares
@ $0
Granted 7,110 options to buy
@ $51.82, valued at
$368.4k
|
|
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2021 |
4
| SULIMAN SHEHNAAZ (President and COO) has filed a Form 4 on Alector, Inc.|
Txns:
| Sold 66,126 shares
@ $21.6855, valued at
$1.4M
Sold 8,874 shares
@ $22.334, valued at
$198.2k
Sold 64,102 shares
@ $21.1592, valued at
$1.4M
Sold 10,898 shares
@ $21.7289, valued at
$236.8k
Exercised 75,000 options to buy
@ $17.23, valued at
$1.3M
Exercised 75,000 options to buy
@ $17.23, valued at
$1.3M
|
|
| 12/10/2021 |
4
| SULIMAN SHEHNAAZ (President and COO) has filed a Form 4 on Alector, Inc.|
Txns:
| Sold 36,511 shares
@ $22.5583, valued at
$823.6k
Sold 38,489 shares
@ $23.0115, valued at
$885.7k
Sold 72,357 shares
@ $22.8034, valued at
$1.6M
Sold 2,643 shares
@ $23.4043, valued at
$61.9k
Exercised 19,813 options to buy
@ $17.23, valued at
$341.4k
Exercised 55,187 options to buy
@ $10.24, valued at
$565.1k
Exercised 75,000 options to buy
@ $17.23, valued at
$1.3M
|
|
| 06/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2021 |
4
| SULIMAN SHEHNAAZ (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Granted 625 shares
@ $0
Granted 1,563 options to buy
@ $193.51, valued at
$302.5k
|
|
| 05/11/2021 |
4
| SULIMAN SHEHNAAZ (President and COO) has filed a Form 4 on Alector, Inc.|
Txns:
| Granted 100,000 shares
@ $0 |
|
| 10/05/2020 |
4
| SULIMAN SHEHNAAZ (President and COO) has filed a Form 4 on Alector, Inc.|
Txns:
| Granted 189,213 options to buy
@ $10.24, valued at
$1.9M
|
|
| 06/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2020 |
4
| SULIMAN SHEHNAAZ (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Granted 4,432 options to buy
@ $88.42, valued at
$391.9k
|
|
| 01/27/2020 |
4
| SULIMAN SHEHNAAZ (President and COO) has filed a Form 4 on Alector, Inc.|
Txns:
| Granted 550,000 options to buy
@ $17.23, valued at
$9.5M
|
|
| 12/12/2019 |
3
| SULIMAN SHEHNAAZ (President and COO) has filed a Form 3 on Alector, Inc. |
| 09/16/2019 |
4
| SULIMAN SHEHNAAZ (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Disposed of 100,000 options to buy
@ $30, valued at
$3M
Acquired 100,000 options to buy
@ $30, valued at
$3M
|
|
| 09/11/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/13/2019 |
4
| SULIMAN SHEHNAAZ (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 3,000 shares
@ $0
Granted 5,000 options to buy
@ $58.74, valued at
$293.7k
|
|
| 02/22/2019 |
4
| SULIMAN SHEHNAAZ (SVP, Corp Dev & Strategy) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Paid exercise price by delivering 5,763 shares
@ $27, valued at
$155.6k
|
|
| 02/01/2019 |
4
| SULIMAN SHEHNAAZ (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 20,000 options to buy
@ $48.85, valued at
$977k
|
|
| 02/01/2019 |
3
| SULIMAN SHEHNAAZ (Director) has filed a Form 3 on Ultragenyx Pharmaceutical Inc. |
| 02/22/2018 |
4
| SULIMAN SHEHNAAZ (SVP, Corp Dev & Strategy) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Paid exercise price by delivering 8,770 shares
@ $29.09, valued at
$255.1k
|
|
| 02/14/2018 |
4
| SULIMAN SHEHNAAZ (SVP, Corp Dev & Strategy) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Granted 65,000 shares
@ $0
Granted 25,000 shares
@ $0 |
|
| 08/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|